Australia's notifiable diseases status, 2008: Annual report of the National Notifiable Diseases Surveillance System - Results: Summary and Tables 4 to 9

The Australia’s notifiable diseases status, 2008 report provides data and an analysis of communicable disease incidence in Australia during 2008. The full report is available in 16 HTML documents. The full report is also available in PDF format from the Table of contents page.

Page last updated: 30 September 2010

This article {extract} was published in Communicable Diseases Intelligence Vol 34 No 3 September 2010 and may be downloaded as a full version PDF from the Table of contents page.

Results

There were 160,508 communicable disease notifications received by NNDSS in 2008 (Table 4).

Table 4: Notifications to the National Notifiable Diseases Surveillance System, Australia, 2008, by disease category rank order

Disease category
Number %
Sexually transmitted infections
69,459
43.3
Vaccine preventable diseases
34,225
21.3
Gastrointestinal diseases
27,308
17.0
Bloodborne diseases
18,207
11.3
Vectorborne diseases
8,876
5.5
Other bacterial diseases
1,796
1.1
Zoonoses
633
0.4
Quarantinable diseases
4
<0.1
Total
160,508
100.0

In 2008, the most frequently notified diseases were sexually transmissible infections (69,459 notifications, 43.3% of total notifications), vaccine preventable diseases (34,225 notifications, 21.3% of total notifications) and gastrointestinal diseases (27,308 notifications, 17% of total notifications).

Top of page

There were 18,207 notifications of bloodborne diseases; 8,876 notifications of vectorborne diseases; 1,796 notifications of other bacterial infections; 633 notifications of zoonoses and 4 notifications of quarantinable diseases. In 2008, the total number of notifications was the highest recorded in the NNDSS since the surveillance system commenced data collection in 1991. There was an increase of 9% compared with the total number of notifications in 2007 (Figure 2).

Figure 2: Trends in notifications received by the National Notifiable Diseases Surveillance System, Australia, 1991 to 2008

Notifications and notification rates per 100,000 population for each disease by state or territory, in 2008, are shown in Table 5 and Table 6 respectively. Trends in notifications and rates per 100,000 population for the period 2003 to 2008 are shown in Table 7.

Table 5: Notifications of communicable diseases, Australia, 2008, by state or territory

Disease
State or territory  
ACT NSW NT* Qld SA Tas Vic WA Aust
Bloodborne diseases
Hepatitis (NEC)
0
0
0
0
0
0
1
0
1
Hepatitis B (newly acquired)
1
46
8
45
11
12
88
34
245
Hepatitis B (unspecified)
67
2,555
197
843
417
58
1,832
631
6,600
Hepatitis C (newly acquired)
5
24
6
NN
65
24
154
103
381
Hepatitis C (unspecified)‡,§
195
3,555
222
2,634
515
324
2,252
1,241
10,938
Hepatitis D
0
14
1
7
0
0
14
6
42
Gastrointestinal diseases
Botulism
0
0
0
0
0
0
0
0
0
Campylobacteriosis||
381
NN
257
4,821
1,992
475
5,780
1,829
15,535
Cryptosporidiosis
11
484
102
695
63
36
449
165
2,005
Haemolytic uraemic syndrome
0
17
1
7
2
0
4
0
31
Hepatitis A
5
69
3
71
20
1
85
22
276
Hepatitis E
0
14
3
7
0
0
14
6
44
Listeriosis
1
34
0
12
1
1
11
8
68
Salmonellosis
132
2,261
497
2,047
661
206
1,651
855
8,310
Shigellosis
3
109
175
97
137
4
134
169
828
STEC,VTEC
0
19
0
37
39
0
11
0
106
Typhoid
0
43
1
18
3
0
32
8
105
Quarantinable diseases
Cholera
0
2
0
0
0
0
0
2
4
Highly pathogenic avian influenza in humans
0
0
0
0
0
0
0
0
0
Plague
0
0
0
0
0
0
0
0
0
Rabies
0
0
0
0
0
0
0
0
0
Severe acute respiratory syndrome
0
0
0
0
0
0
0
0
0
Smallpox
0
0
0
0
0
0
0
0
0
Viral haemorrhagic fever
0
0
0
0
0
0
0
0
0
Yellow fever
0
0
0
0
0
0
0
0
0
Sexually transmitted infections
Chlamydial infection**
988
14,019
2,296
15,197
3,653
1,481
12,210
8,640
58,484
Donovanosis
0
0
1
1
0
0
0
0
2
Gonococcal infection††
21
1,332
1,567
1,638
521
25
926
1,693
7,723
Syphilis – all‡‡
36
1,407
253
390
52
22
793
290
3,243
Syphilis < 2 years duration
4
416
83
187
52
7
374
180
1,303
Syphilis > 2 years or unspecified duration
32
991
170
203
NDP
15
419
110
1,940
Syphilis – congenital
0
3
1
3
0
0
0
0
7
Vaccine preventable diseases
Diphtheria
0
0
0
0
0
0
0
0
0
Haemophilus influenzae type b
0
9
2
6
1
1
6
0
25
Influenza (laboratory confirmed)§§
244
1,814
199
3,703
473
388
1,300
1,016
9,137
Measles
0
39
3
11
2
0
2
8
65
Mumps
0
77
53
29
17
2
13
95
286
Pertussis
145
7,818
477
2,260
1,459
200
1,694
463
14,516
Pneumococcal disease (invasive)
20
547
60
326
120
39
355
162
1,629
Poliomyelitis
0
0
0
0
0
0
0
0
0
Rubella
0
17
0
4
1
0
8
7
37
Rubella – congenital
0
0
0
0
0
0
0
0
0
Tetanus
0
1
0
1
0
0
1
1
4
Varicella zoster (chickenpox)||||
12
NN
115
429
620
29
230
355
1,790
Varicella zoster (shingles)||||
7
NN
106
447
931
125
185
508
2,309
Varicella zoster (unspecified)||||
102
NN
2
3,138
223
46
162
754
4,427
Vectorborne diseases
Arbovirus infection (NEC)¶¶
0
1
0
21
0
0
6
0
28
Barmah Forest virus infection
7
533
76
1,242
37
1
32
174
2,102
Dengue virus infection
6
154
23
232
31
6
8
98
558
Japanese encephalitis virus infection
0
1
0
0
0
0
0
0
1
Kunjin virus infection***
0
0
0
1
0
0
0
0
1
Malaria
15
116
20
167
17
8
105
85
533
Murray Valley encephalitis virus infection***
0
1
0
0
0
0
0
1
2
Ross River virus infection
21
1,152
261
2,838
197
77
231
874
5,651
Zoonoses
Anthrax
0
0
0
0
0
0
0
0
0
Australia bat lyssavirus
0
0
0
0
0
0
0
0
0
Brucellosis
0
2
0
46
0
0
0
0
48
Leptospirosis
0
17
1
89
0
0
4
1
112
Lyssavirus (NEC)
0
0
0
0
0
0
0
0
0
Ornithosis
0
41
0
3
0
0
53
6
103
Q fever
2
164
3
158
17
0
20
6
370
Tularaemia
0
0
0
0
0
0
0
0
0
Other bacterial diseases
Legionellosis
4
89
1
31
21
1
54
70
271
Leprosy
0
4
1
2
0
0
2
2
11
Meningococcal infection†††
3
81
8
85
20
1
64
24
286
Tuberculosis
12
501
32
144
54
8
379
98
1,228
Total
2,446
39,186
7,034
43,983
12,393
3,601
31,355
20,510
160,508

* Due to delays in data quality checks, data for Northern Territory was preliminary at the time of analysis.

† Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis.

‡ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined.

§ In Queensland, includes incident hepatitis C cases.

|| Notified as 'foodborne disease' or 'gastroenteritis in an institution' in New South Wales.

¶ Infection with Shiga toxin/verotoxin-producing Escherichia coli (STEC/VTEC).

** Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral, throat and eye samples, except for South Australia, which reports only genital tract specimens; the Northern Territory and Western Australia excludes ocular infections. Where data fields were complete, infections defined as non-sexually acquired (e.g. perinatal) in individuals aged less than 13 years, were excluded from the data.

†† Where data fields were complete, gonococcal infections defined as non-sexually acquired (e.g. perinatal) in individuals aged less than 13 years, were excluded from the data.

‡‡ Does not include congenital syphilis. §§ Influenza (laboratory confirmed) became notifiable in South Australia on 1 May 2008.

|||| Varicella zoster became notifiable in Victoria on 21 September 2008.

¶¶ Arbovirus (NEC) replaced Flavivirus (NEC) in 2008.

*** In the Australian Capital Territory, Murray Valley encephalitis virus infection and Kunjin virus infection are combined under Murray Valley encephalitis virus infection.

††† Only invasive meningococcal disease is nationally notifiable. However, New South Wales, the Australian Capital Territory and South Australia also report conjunctival cases.

NEC Not elsewhere classified.

NN Not notifiable.

NDP No data provided.

Top of page

Table 6: Notification rates of nationally notifiable communicable diseases, Australia, 2008, by state or territory. (Annualised rate per 100,000 population)

Disease
State or territory  
ACT NSW NT* Qld SA Tas Vic WA Aust
Bloodborne diseases
Hepatitis (NEC)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Hepatitis B (newly acquired)
0.3
0.7
3.6
1.0
0.7
2.4
1.7
1.6
1.1
Hepatitis B (unspecified)
19.4
36.6
89.6
19.6
26.0
11.7
34.5
29.1
30.8
Hepatitis C (newly acquired)
1.4
0.3
2.7
NN
4.1
4.8
2.9
4.7
2.2
Hepatitis C (unspecified)‡,§
56.4
50.9
101.0
61.3
32.1
65.1
42.4
57.2
51.0
Hepatitis D
0.0
0.2
0.5
0.2
0.0
0.0
0.3
0.3
0.2
Gastrointestinal diseases
Botulism
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Campylobacteriosis||
110.3
NN
116.9
112.3
124.2
95.5
108.8
84.2
107.5
Cryptosporidiosis
3.2
6.9
46.4
16.2
3.9
7.2
8.4
7.6
9.4
Haemolytic uraemic syndrome
0.0
0.2
0.5
0.2
0.1
0.0
0.1
0.0
0.1
Hepatitis A
1.4
1.0
1.4
1.7
1.2
0.2
1.6
1.0
1.3
Hepatitis E
0.0
0.2
1.4
0.2
0.0
0.0
0.3
0.3
0.2
Listeriosis
0.3
0.5
0.0
0.3
0.1
0.2
0.2
0.4
0.3
Salmonellosis
38.2
32.4
226.1
47.7
41.2
41.4
31.1
39.4
38.8
Shigellosis
0.9
1.6
79.6
2.3
8.5
0.8
2.5
7.8
3.9
STEC,VTEC
0.0
0.3
0.0
0.9
2.4
0.0
0.2
0.0
0.5
Typhoid
0.0
0.6
0.5
0.4
0.2
0.0
0.6
0.4
0.5
Quarantinable diseases
Cholera
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
Highly pathogenic avian influenza in humans
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Plague
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Rabies
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Severe acute respiratory syndrome
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Smallpox
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Viral haemorrhagic fever
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Yellow fever
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Sexually transmitted infections
Chlamydial infection**
285.9
200.7
1044.5
353.9
227.8
297.7
229.8
397.9
272.9
Donovanosis
0.0
0.0
0.5
0.0
0.0
0.0
0.0
0.0
0.0
Gonococcal infection††
6.1
19.1
712.9
38.1
32.5
5.0
17.4
78.0
36.0
Syphilis – all‡‡
10.4
20.2
115.1
9.1
3.2
4.4
14.9
13.4
15.1
Syphilis < 2 years duration
1.2
6.0
37.8
4.4
3.2
1.4
7.0
8.3
6.1
Syphilis > 2 years or unspecified duration
9.3
14.2
77.3
4.7
NDP
3.0
7.9
5.1
9.8
Syphilis – congenital
0.0
0.0
0.5
0.1
0.0
0.0
0.0
0.0
0.0
Vaccine preventable diseases
Diphtheria
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Haemophilus influenzae type b
0.0
0.1
0.9
0.1
0.1
0.2
0.1
0.0
0.1
Influenza (laboratory confirmed)§§
70.6
26.0
90.5
86.2
29.5
78.0
24.5
46.8
42.6
Measles
0.0
0.6
1.4
0.3
0.1
0.0
0.0
0.4
0.3
Mumps
0.0
1.1
24.1
0.7
1.1
0.4
0.2
4.4
1.3
Pertussis
42.0
111.9
217.0
52.6
91.0
40.2
31.9
21.3
67.7
Pneumococcal disease (invasive)
5.8
7.8
27.3
7.6
7.5
7.8
6.7
7.5
7.6
Poliomyelitis
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Rubella
0.0
0.2
0.0
0.1
0.1
0.0
0.2
0.3
0.2
Rubella – congenital
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Tetanus
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Varicella zoster (chickenpox)||||
3.5
NN
52.3
10.0
38.7
5.8
NRC
16.4
19.6
Varicella zoster (shingles)||||
2.0
NN
48.2
10.4
58.1
25.1
NRC
23.4
25.3
Varicella zoster (unspecified)||||
29.5
NN
0.9
73.1
13.9
9.2
NRC
34.7
48.5
Vectorborne diseases
Arbovirus infection (NEC)¶¶
0.0
0.0
0.0
0.5
0.0
0.0
0.1
0.0
0.1
Barmah Forest virus infection
2.0
7.6
34.6
28.9
2.3
0.2
0.6
8.0
9.8
Dengue virus infection
1.7
2.2
10.5
5.4
1.9
1.2
0.2
4.5
2.6
Japanese encephalitis virus infection
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Kunjin virus infection***
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Malaria
4.3
1.7
9.1
3.9
1.1
1.6
2.0
3.9
2.5
Murray Valley encephalitis virus infection***
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Ross River virus infection
6.1
16.5
118.7
66.1
12.3
15.5
4.3
40.3
26.4
Zoonoses
Anthrax
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Australia bat lyssavirus
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Brucellosis
0.0
0.0
0.0
1.1
0.0
0.0
0.0
0.0
0.2
Leptospirosis
0.0
0.2
0.5
2.1
0.0
0.0
0.1
0.0
0.5
Lyssavirus (NEC)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Ornithosis
0.0
0.6
0.0
0.1
0.0
0.0
1.0
0.3
0.5
Q fever
0.6
2.3
1.4
3.7
1.1
0.0
0.4
0.3
1.7
Tularaemia
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Other bacterial diseases
Legionellosis
1.2
1.3
0.5
0.7
1.3
0.2
1.0
3.2
1.3
Leprosy
0.0
0.1
0.5
0.0
0.0
0.0
0.0
0.1
0.1
Meningococcal infection†††
0.9
1.2
3.6
2.0
1.2
0.2
1.2
1.1
1.3
Tuberculosis
3.5
7.2
14.6
3.4
3.4
1.6
7.1
4.5
5.7

* Due to delays in data quality checks, data for Northern Territory was preliminary at the time of analysis.

† Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis.

‡ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined.

§ In Queensland, includes incident hepatitis C cases.

|| Notified as 'foodborne disease' or 'gastroenteritis in an institution' in New South Wales.

¶ Infection with Shiga toxin/verotoxin-producing Escherichia coli (STEC/VTEC).

** Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral, throat and eye samples, except for South Australia, which reports only genital tract specimens; the Northern Territory and Western Australia excludes ocular infections. Where data fields were complete, infections defined as non-sexually acquired (e.g. perinatal) in individuals aged less than 13 years, were excluded from the data.

†† Where data fields were complete, gonococcal infections defined as non-sexually acquired (e.g. perinatal) in individuals aged less than 13 years, were excluded from the data.

‡‡ Does not include congenital syphilis.

§§ Influenza (laboratory confirmed) became notifiable in South Australia on 1 May 2008.

|||| Varicella zoster became notifiable in Victoria on 21 September 2008.

¶¶ Arbovirus (NEC) replaced Flavivirus (NEC) in 2008.

*** In the Australian Capital Territory, Murray Valley encephalitis virus infection and Kunjin virus infection are combined under Murray Valley encephalitis virus infection.

††† Only invasive meningococcal disease is nationally notifiable. However, New South Wales, the Australian Capital Territory and South Australia also report conjunctival cases.

NEC Not elsewhere classified.

NN Not notifiable.

NDP No data provided.

NRC No rate calculated – due to part year reporting. Varicella zoster became notifiable in Victoria on 21 September 2008.

Top of page

Table 7: Notifications and notification rate per 100,000 population for communicable diseases, Australia, 2003 to 2008

Disease
Number of notifications 5 year mean Ratio Notification rate per 100,000 population
  2003 2004 2005 2006 2007 2008 2003 2004 2005 2006 2007 2008
Bloodborne diseases
Hepatitis (NEC)
1
1
1
0.4
2.5
0.0
0.0
0.0
0.0
0.0
0.0
Hepatitis B (newly acquired)*
347
283
251
291
294
245
293.2
0.8
1.7
1.4
1.2
1.4
1.4
1.1
Hepatitis B (unspecified)
5,803
5,781
6,291
6,254
6,887
6,600
6,203.2
1.1
29.2
28.7
30.8
30.2
32.7
30.8
Hepatitis C (newly acquired)*
514
456
373
436
385
381
432.8
0.9
3.2
2.8
2.3
2.6
2.3
2.2
Hepatitis C (unspecified)†,‡
13,606
12,661
11,955
11,931
11,905
10,938
12,411.6
0.9
68.4
62.9
58.6
57.6
56.5
51.0
Hepatitis D
26
29
32
30
34
42
30.2
1.4
0.1
0.1
0.2
0.1
0.2
0.2
Gastrointestinal diseases
Botulism
1
1
3
1
1
1.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Campylobacteriosis§
15,360
15,589
16,497
15,423
16,996
15,535
15,973.0
1.0
116.2
116.2
121.0
111.1
120.0
107.5
Cryptosporidiosis
1,222
1,685
3,215
3,203
2,812
2,005
2,427.4
0.8
6.1
8.4
15.8
15.5
13.3
9.4
Haemolytic uraemic syndrome
15
16
20
14
19
31
16.8
1.8
0.1
0.1
0.1
0.1
0.1
0.1
Hepatitis A
431
319
327
281
165
276
304.6
0.9
2.2
1.6
1.6
1.4
0.8
1.3
Hepatitis E
12
28
30
24
18
44
22.4
2.0
0.1
0.1
0.1
0.1
0.1
0.2
Listeriosis
69
67
54
61
50
68
60.2
1.1
0.3
0.3
0.3
0.3
0.2
0.3
Salmonellosis
7,001
7,839
8,424
8,255
9,533
8,310
8,210.4
1.0
35.2
38.9
41.3
39.9
45.2
38.8
Shigellosis
442
520
729
546
602
828
567.8
1.5
2.2
2.6
3.6
2.6
2.9
3.9
STEC,VTEC||
52
49
86
70
107
106
72.8
1.5
0.3
0.2
0.4
0.3
0.5
0.5
Typhoid
51
76
52
77
91
105
69.4
1.5
0.3
0.4
0.3
0.4
0.4
0.5
Quarantinable diseases
Cholera
1
5
3
3
4
4
3.2
1.3
0.0
0.0
0.0
0.0
0.0
0.0
Highly pathogenic avian influenza in humans
0
0
0
0
0
0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Plague
0
0
0
0
0
0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Rabies
0
0
0
0
0
0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Severe acute respiratory syndrome
0
0
0
0
0
0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Smallpox
0
0
0
0
0
0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Viral haemorrhagic fever
0
0
0
0
0
0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Yellow fever
0
0
0
0
0
0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Sexually transmissible infections
Chlamydial infection
30,419
36,212
41,346
47,458
52,022
58,484
41,491.4
1.4
152.9
179.9
202.7
229.3
246.9
272.9
Donovanosis
16
10
13
6
3
2
9.6
0.2
0.1
0.0
0.1
0.0
0.0
0.0
Gonococcal infection**
6,779
7,175
8,070
8,562
7,676
7,723
7,652.4
1.0
34.1
35.6
39.6
41.4
36.4
36.0
Syphilis – all††
2,004
2,347
2,234
2,687
3,161
3,243
2,486.6
1.3
10.1
11.7
11.0
13.0
15.0
15.1
Syphilis < 2 years duration
NN
634
650
878
1,422
1,303
716.8‡‡
1.8
NN
3.1
3.2
4.2
6.7
6.1
Syphilis > 2 years or unspecified duration
NN
1,713
1,584
1,809
1,739
1,940
1,369.0‡‡
1.4
NN
9.2
8.4
9.5
8.9
9.8
Syphilis – congenital
13
13
15
14
7
7
12.4
0.6
0.1
0.1
0.1
0.1
0.0
0.0
Vaccine preventable diseases
Diphtheria
0
0
0
0
0
0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Haemophilus influenzae type b
19
15
17
22
17
25
18.0
1.4
0.1
0.1
0.1
0.1
0.1
0.1
Influenza (laboratory confirmed)§§
3,479
2,138
4,561
3,254
10,449
9,137
4,776.2
1.9
17.5
10.6
22.4
15.7
49.6
42.6
Measles
93
45
10
125
12
65
57.0
1.1
0.5
0.2
0.0
0.6
0.1
0.3
Mumps
77
102
240
275
586
286
256.0
1.1
0.4
0.5
1.2
1.3
2.8
1.3
Pertussis
5,096
8,750
11,200
10,995
5,345
14,516
8,277.2
1.8
25.6
43.5
54.9
53.1
25.4
67.7
Pneumococcal disease (invasive)
2,226
2,373
1,706
1,463
1,483
1,629
1,850.2
0.9
11.2
11.8
8.4
7.1
7.0
7.6
Poliomyelitis
0
0
0
0
1
0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Rubella
55
31
31
59
34
37
42.0
0.9
0.3
0.2
0.2
0.3
0.2
0.2
Rubella – congenital
3
1
1
0
2
0
1.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Tetanus
4
5
2
3
3
4
3.4
1.2
0.0
0.0
0.0
0.0
0.0
0.0
Varicella zoster (chickenpox)||||
NN
NN
NN
1,558
1,667
1,790
1,080.3¶¶
1.7
NN
NN
NN
17.8
18.6
19.6
Varicella zoster (shingles)||||
NN
NN
NN
1,092
1,561
2,309
886.7¶¶
2.6
NN
NN
NN
12.5
17.4
25.3
Varicella zoster (unspecified)||||
NN
NN
NN
3,677
4,286
4,427
2,701.3¶¶
1.6
NN
NN
NN
42.0
47.9
48.5
Vectorborne diseases
Arbovirus infection (NEC)***
58
60
28
32
22
28
40.0
0.7
0.3
0.3
0.1
0.2
0.1
0.1
Barmah Forest virus infection
1,367
1,103
1,323
2,140
1,716
2,102
1,529.8
1.4
6.9
5.5
6.5
10.3
8.1
9.8
Dengue virus infection
861
351
220
187
314
558
386.6
1.4
4.3
1.7
1.1
0.9
1.5
2.6
Japanese encephalitis virus infection
1
1
1
0.4
2.5
0.0
0.0
0.0
0.0
0.0
0.0
Kunjin virus infection†††
9
6
1
3
1
1
4.0
0.3
0.0
0.0
0.0
0.0
0.0
0.0
Malaria
585
547
817
770
568
533
657.4
0.8
2.9
2.7
4.0
3.7
2.7
2.5
Murray Valley encephalitis virus infection†††
1
2
1
2
0.8
2.5
0.0
0.0
0.0
0.0
0.0
0.0
Ross River virus infection
3,844
4,209
2,540
5,545
4,207
5,651
4,069.0
1.4
19.3
20.9
12.5
26.8
20.0
26.4
Zoonoses
Anthrax
0
0
0
1
1
0
0.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Brucellosis
20
38
41
51
38
48
37.6
1.3
0.1
0.2
0.2
0.2
0.2
0.2
Leptospirosis
127
177
129
145
108
112
137.2
0.8
0.6
0.9
0.6
0.7
0.5
0.5
Ornithosis
200
239
164
165
93
103
172.2
0.6
1.0
1.2
0.8
0.8
0.4
0.5
Q fever
560
463
351
408
445
370
445.4
0.8
2.8
2.3
1.7
2.0
2.1
1.7
Other bacterial infections
Legionellosis
333
312
331
349
306
271
326.2
0.8
1.7
1.6
1.6
1.7
1.5
1.3
Leprosy
7
6
10
7
13
11
8.6
1.3
0.0
0.0
0.0
0.0
0.1
0.1
Meningococcal infection‡‡‡
558
405
391
318
306
286
395.6
0.7
2.8
2.0
1.9
1.5
1.5
1.3
Tuberculosis
986
1,052
1,083
1,208
1,174
1,228
1,100.6
1.1
5.0
5.2
5.3
5.8
5.6
5.7
Total
102,748
113,593
125,384
139,481
147,530
160,508
125,747.2

 

* Newly acquired hepatitis includes cases in whom the infection was determined to be acquired within 24 months prior to diagnosis.

† Unspecified hepatitis and syphilis includes cases in whom the duration of infection could not be determined.

‡ Data provided from Queensland (2003–2008) and the Northern Territory (2003–2004) includes both newly-acquired and unspecified hepatitis C notifications.

§ Notified as 'foodborne disease' or 'gastroenteritis in an institution' in New South Wales.

|| Infection with Shiga toxin/verotoxin-producing Escherichia coli (STEC/VTEC).

¶ Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral, throat and eye samples, except for South Australia, which reports only genital tract specimens; the Northern Territory and Western Australia excludes ocular infections. Where data fields were complete, infections defined as non-sexually acquired (e.g. perinatal) in individuals aged less than 13 years, were excluded from the data.

** Where data fields were complete, infections defined as non-sexually acquired (e.g. perinatal) in individuals aged less than 13 years, were excluded from the data.

†† Does not include congenital syphilis.

‡‡ Ratios for Syphilis < 2 years; syphilis > 2 years or unspecified duration are based on 4 years data.

§§ Influenza (laboratory confirmed) became notifiable in South Australia on 1 May 2008.

|||| Nationally notifiable in 2006 and first full year of national reporting from 2007. Varicella zoster became notifiable in Victoria on 21 September 2008.

¶¶ Ratios for varicella zoster (chickenpox); varicella zoster (shingles); and varicella zoster (unspecified) are based on 2 years data.

*** Arbovirus (NEC) replaced Flavivirus (NEC) in 2008.

††† In the Australian Capital Territory, Murray Valley encephalitis virus infection and Kunjin virus infection are combined under Murray Valley encephalitis virus infection.

‡‡‡ Only invasive meningococcal disease is nationally notifiable. However, New South Wales, the Australian Capital Territory and South Australia also report conjunctival cases.

NEC Not elsewhere classified.

NN Not notifiable.

Top of page

The year in which diseases became notifiable to NNDSS in each jurisdiction is shown in Table 8.

Table 8: Earliest notification year for which NNDSS contains disease data, Australia, by state or territory*

Disease
Year in which data first sent to Commonwealth Period of national reporting
Exceptions to national reporting
ACT NSW NT Qld SA Tas Vic WA    
Bloodborne diseases
Hepatitis (NEC)
1991
1991
1991
1991
1991
1991
1991
NN
1991 to present
WA do not report
Hepatitis B (newly acquired)
1995
1993
1993
1994
1993
1993
1993
1994
1995 to present
 
Hepatitis B (unspecified)
1991
1991
2004
1994
1991
1991
1991
1991
1991 to present
 
Hepatitis C (newly acquired)
1995
1993
2005
NN
1993
1995
1997
1995
1993 to present
All jurisdictions except Qld
Hepatitis C (unspecified)
1991
1991
1991
1991
1994
1991
1991
1993
1995 to present
Includes reports of incident hepatitis C, 1991 to 1994
Hepatitis D
1999
1999
1999
1997
1999
1999
1999
2001
1999 to present
WA did not report 1999–2000
Gastrointestinal diseases
Botulism
1992
1998
1998
1997
1993
1992
1992
2001
1992 to present
State reporting started as shown
Campylobacteriosis
1991
NN
1991
1991
1991
1991
1991
1991
1991 to present
NSW do not report
Cryptosporidiosis
2001
2001
2001
1996
2001
2001
2001
2001
2001 to present
 
Haemolytic uraemic syndrome
1999
1999
1999
1997
1999
1999
1999
1999
1999 to present
 
Hepatitis A
1991
1991
1991
1991
1991
1991
1991
1991
1991 to present
 
Hepatitis E
1999
1999
1999
1999
1999
1999
1999
2001
1999 to present
WA did not report 1999–2000
Listeriosis
1991
1991
1994
1991
1992
1991
1991
1991
1991 to present
SA did not report 1991
NT did not report 1991–1993
Salmonellosis
1991
1991
1991
1991
1991
1991
1991
1991
1991 to present
 
Shigellosis
1991
2001
1991
1997
1991
1991
1991
1991
1991 to present
NSW did not report 1991–2000
Qld did not report 1991–1996
STEC, VTEC
1999
1999
1999
2002
1999
1999
1999
2001
1999 to present
Qld did not report 1991–2001
WA did not report 1999–2000
Typhoid
1991
1991
1991
1991
1991
1991
1991
1991
1991 to present
 
Quarantinable diseases
Cholera
1991
1991
1991
1991
1991
1991
1991
1991
1991 to present
 
Highly pathogenic avian influenza in humans
2004
2004
2004
2004
2004
2004
2004
2004
2004 to present
 
Plague
1991
1991
1991
1991
1991
1991
1991
1991
1991 to present
 
Rabies
1993
1997
1991
1991
1991
1991
1991
1991
1991 to present
 
Severe acute respiratory syndrome
2003
2003
2003
2003
2003
2003
2003
2003
2003 to present
 
Smallpox
2004
2004
2004
2004
2004
2004
2004
2004
2004 to present
 
Viral haemorrhagic fever
1993
1991
1991
1991
1991
1991
1991
1991
1991 to present
 
Yellow fever
1991
1991
1991
1991
1991
1991
1991
1991
1991 to present
 
Sexually transmissible infections
Chlamydial infection (NEC)
1993
1991
1991
1991
1993
1991
1991
1993
1994 to present
NSW did not report 1994–1998
Donovanosis
1991
2002
1991
1991
2002
1993
1991
1991
1991 to present
NSW and SA did not report 1991–2001
Tasmania did not report 1991–1992
Gonococcal infection
1991
1993
1991
1991
1991
1991
1991
1991
1991 to present
 
Syphilis – all§
1991
1991
1991
1991
1991
1991
1991
1991
1991 to present
 
Syphilis < 2 years
2004
2004
2004
2004
2004
2004
2004
2004
2004 to present
 
Syphilis > 2 years or unspecified duration
2004
2004
2004
2004
2004
2004
2004
2004
2004 to present
 
Syphilis – congenital
2003
2003
2003
2003
2003
2003
2003
2003
2003 to present
 
Vaccine preventable diseases
Diphtheria
1991
1991
1991
1991
1991
1991
1991
1991
1991 to present
 
Haemophilus influenzae type b
1991
1991
1991
1991
1991
1991
1991
1994
1991 to present
WA did not report 1991–1993
Influenza (laboratory confirmed)
2001
2001
2001
2001
2001
2001
2001
2001
2001 to present
 
Measles
1991
1991
1991
1991
1991
1991
1991
1991
1991 to present
 
Mumps
1992
1992
1995
1997
1994
1995
1992
1994
1995 to present
Qld did not report (1992–1996 and 2000)
Pertussis
1991
1991
1991
1991
1991
1991
1991
1991
1991 to present
 
Pneumococcal disease (invasive)
2001
2001
2001
1997
2001
2001
2001
2001
2001 to present
 
Poliomyelitis
1991
1991
1991
1991
1991
1991
1991
1991
1991 to present
 
Rubella||
1991
1991
1993
1991
1993
1995
1992
1994
1993 to present
Tasmania did not report 1993–1994
Rubella – congenital
2003
2003
2003
1997
2003
2003
2003
2003
2003 to present
 
Tetanus
1991
1991
1991
1997
1991
1991
1991
1991
1991 to present
Qld did not report 1991–1996
Varicella zoster (chickenpox)
2006
NN
2006
2006
2006
2006
2008
2006
2006 to present
All jurisdictions except NSW Reported by Victoria in September 2008
Varicella zoster (shingles)
2006
NN
2006
2006
2006
2006
2008
2006
2006 to present
All jurisdictions except NSW Reported by Victoria in September 2008
Varicella zoster (unspecified)
2006
NN
2006
2006
2006
2006
2008
2006
2006 to present
All jurisdictions except NSW Reported by Victoria in September 2008
Vectorborne diseases
Barmah Forest virus infection
1995
1995
1997
1995
1995
1995
1995
1995
1995 to present
 
Dengue virus infection
1993
1991
1991
1991
1991
1991
1991
1995
1991 to present
ACT did not report 1991–1992
Arbovirus infection (NEC)¶,**
1991
1991
1991
1991
1991
1991
1991
1991
1991 to present
Includes JEV, MVEV and Kunjin 1991–2000
Japanese encephalitis virus infection
2001
2001
2001
2001
2001
2001
2001
2001
2001 to present
 
Kunjin virus
2001
2001
2001
2001
2001
2001
2001
2001
2001 to present
Reported under MVEV in ACT
Malaria
1991
1991
1991
1991
1991
1991
1991
1991
1991 to present
 
Murray Valley encephalitis virus infection
2001
2001
2001
2001
2001
2001
2001
2001
2001 to present
Combined with Kunjin in ACT
Ross River virus infection
1993
1993
1991
1991
1993
1993
1991
1991
1993 to present
 
Zoonoses
Anthrax
2001
2001
2001
1991
2002
2001
2001
2001
2001 to present
 
Australian bat lyssavirus
2001
2001
2001
1998
2001
2001
2001
2001
2001 to present
 
Brucellosis
1991
1991
1991
1991
1991
1991
1991
1991
1991 to present
 
Leptospirosis
1991
1991
1991
1991
1991
1991
1991
1991
1991 to present
 
Lyssavirus (NEC)
2001
2001
2001
1998
2001
2001
2001
2001
2001 to present
 
Ornithosis
1991
2001
1991
1992
1991
1991
1991
1991
1991 to present
NSW did not report 1991–2000
Qld did not report 1997–2001
Q fever
1991
1991
1991
1991
1991
1991
1991
1991
1991 to present
 
Tularaemia
2004
2004
2004
2004
2004
2004
2004
2004
2004 to present
 
Other bacterial infections
Legionellosis
1991
1991
1991
1991
1991
1991
1991
1991
1991 to present
 
Leprosy
1991
1991
1991
1991
1991
1991
1991
1991
1991 to present
 
Meningococcal infection
1991
1991
1991
1991
1991
1991
1991
1991
1991 to present
 
Tuberculosis
1991
1991
1991
1991
1991
1991
1991
1991
1991 to present
 

* Data from the National Notifiable Diseases Surveillance System annual reports from 1991. First full year of reporting to the Department of health and Ageing is shown. Some diseases may have been notifiable to state or territory health departments before the dates shown here.

† Includes paratyphoid in New South Wales, Queensland and Victoria.

‡ Includes neonatal ophthalmia in the Northern Territory, Queensland, South Australia, and Victoria.

§ Includes syphilis – congenital from 1991 to 2002.

|| Includes rubella – congenital from 1991 to 2002.

¶ Before 1997, includes Ross River virus infection, dengue virus infection and Barmah Forest virus infection.

** Flavivirus (NEC) replaced arbovirus (NEC) 1 January 2004. Arbovirus (NEC) replaced Flavivirus (NEC) in 2008.

NN Not Notifiable

Top of page

The major changes in communicable disease notifications in 2008 are shown in Figure 3 as the ratio of notifications in 2008 to the mean number of notifications for the previous 5 years, or in the case of infectious syphilis < 2 year duration, 4 years. Notifications of Murray Valley encephalitis virus infection, Haemophilus influenzae type b, haemolytic uraemic syndrome (HUS), shigellosis and pertussis were highest since 2003 and surpassed the expected range (5-year mean plus 2 standard deviations). Notifications of mumps, chlamydial infection, syphilis < 2 years duration, measles, tuberculosis, donovanosis and Shiga toxin/verotoxin-producing Escherichia coli (STEC/VTEC) were within the historical range.

Figure 3: Comparison of total notifications of selected diseases reported to the National Notifiable Diseases Surveillance System in 2008, with the previous 5-year mean

Figure 3:  Comparison of total notifications of selected diseases reported to the National Notifiable Diseases Surveillance System in 2008, with the previous 5-year mean

* Exceeded 2 standard deviations above the 5 year mean.

† Syphilis < 2 years duration based on a 4-year mean.

Top of page

Data completeness

The case's sex was complete for 99.8% of notifications and age at onset for close to 100% of notifications (Table 9). In 2008, indigenous status was complete for 49.9% of notifications, and varied by jurisdiction. Indigenous status was complete for 92.5% of data reported in the Northern Territory, 85.0% in South Australia and 77.7% in Western Australia. In the remaining jurisdictions, less than 57% of data were complete for indigenous status.

Table 9: Completeness of National Notifiable Diseases Surveillance System data received, Australia, 2008, by state or territory*

  State or territory  
  ACT NSW NT Qld SA Tas Vic WA Aust
Total notifications
2,446
39,186
7,034
43,983
12,393
3,601
31,355
20,510
160,508
Sex
Unknown/ missing
2
121
5
2
1
1
193
1
326
Per cent complete
99.9
99.7
99.9
100.0
100.0
100.0
99.4
100.0
99.8
Age at onset
Unknown/ missing
0
0
0
0
1
0
47
0
48
Per cent complete
100.0
100.0
100.0
100.0
100.0
100.0
99.9
100.0
100.0
Indigenous status
Unknown/ missing
2,162
29,290
531
25,841
1,854
1,572
14,592
4,565
80,407
Per cent complete
11.6
25.3
92.5
41.2
85.0
56.3
53.5
77.7
49.9

* Indigenous status is usually obtained from medical notification and completeness varies by disease and by state and territory. This reflects differences in notification requirements (i.e. depending on the jurisdiction, some diseases are primarily or completely notified by pathology laboratories rather than clinicians) and the fact that it is not possible to follow-up all cases for diseases with a large volume of notifications and/or not requiring specific case-based public health action.

† Due to delays in data quality checks, data for the Northern Territory were preliminary at the time of analysis.

Data completeness on indigenous status also varied by disease as summarised in Appendix 3. There were 5 diseases for which notifications were 100% complete for indigenous status.10 A further 5 diseases equalled or exceeded 90% completeness for indigenous status. Of the 18 priority diseases agreed to by CDNA and the NSC in 2008 for improving Indigenous identification, seven had an indigenous completeness that exceeded 90% (donovanosis, leprosy, measles, tuberculosis, meningococcal infection, Haemophilus influenzae type b, syphilis < 2 years duration). The diseases for which there was less than 90% Indigenous completeness included hepatitis A, pneumococcal disease (invasive), shigellosis, gonococcal infection, and locally-acquired dengue virus infection. HIV, which is one of the priority diseases, is not reported to the NNDSS. In 2008, CDNA set target thresholds of 95% completeness for key diseases and 80% completeness for the remainder of the notifiable diseases.

Communicable Diseases Intelligence subscriptions

Sign-up to email updates: Subscribe Now